Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
2026 May 26:102384
In September 2023, the FDA added BPC-157 to its Category 2 list of bulk drug substances under its Interim Policy on Compounding, meaning 503A compounding pharmacies and 503B outsourcing facilities are barred from using it in compounded preparations
10.2174/138945006778559166 Curr
While human clinical trials remain limited, decades of animal research and growing community experience suggest a favorable risk profile when used responsibly
US$ 23.21
US$ 29.79
US$ 26.79
US$ 25.70
US$ 22.74
US$ 23.01
US$ 22.85
US$ 25.36
US$ 23.49
